Goran Ando

Track

Insider profile

Currently holds positions in EyePoint Inc and Cartesian Therapeutics, Inc.

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 36% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board EyePoint Inc Sept. 10, 2018 -
Independent Director Cartesian Therapeutics, Inc. April 24, 2020 -
Non-Executive Vice Chairman of the Board Molecular Partners AG Jan. 1, 2018 - April 29, 2020
Director EyePoint Inc June 26, 2018 - Sept. 10, 2018
Non-Executive Director Molecular Partners AG Jan. 1, 2010 - Jan. 1, 2018
Goran Ando's trades of EyePoint Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US EyePoint Inc (EYPT)
Transaction date
Purchase
Price
290.97
Quantity 88,920 +35.5%
Value US$1,820,003
Transaction date
Purchase
Price
91.19
Quantity 10,632 -43.1%
Value US$93,315
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-21 2024-08-21
US EyePoint Inc (EYPT)
B Purchase
88,920 +35.5%
290.97
US$1,820,003 		88,920 +35.5% 290.97 US$1,820,003
2008-11-17 2008-11-14
B Purchase
10,632 -43.1%
91.19
US$93,315 		10,632 -43.1% 91.19 US$93,315